High growth equities were under some pressure in trading Thursday morning. Overall, the high growth portfolio has fallen about 3%. There is still tariff angst as the president has sent aggressive letters to some trade partners such as Brazil threatening punitive tariffs because of political issues. Further, the QQQs and other indices made all-time highs…
Shares of Rubrik spiked a little this morning and I got off a sale of 300 shares at my limit of $96.99. I had tried for more, but this was the best price at which I got a fill. Investors-or dare I say traders have been very picky with how they react to earnings. Shares of both…
Summary Dynatrace is one of the clear leaders in the observability space, driven by differentiated AI technology (Davis) and a robust platform approach (Grail, DPS). Despite macroeconomic uncertainties, Dynatrace’s prudent guidance, strong pipeline growth, and expanding enterprise focus position it for revenue acceleration beyond current forecasts. The company’s simple, transparent pricing and successful channel strategy—especially…
AS we had discussed in this week’s commentary, we believed that the recent appreciation of IT stocks had taken some of the positions in the portfolio to valuations that were a bit stressed. Today, that opinion was seconded by the analyst team at Raymond James with regards to Nutanix. That precipitated our sale of a…
Sale of 150 shares of Dynatrace (remaining position); Purchase of 30 shares of Datadog; Purchase of 150 shares of Nutanix. Dynatrace: We eliminated the last of our Dynatrace (DT) position this morning. We were sorry to have to eliminate the position, but at this point the growth divergence between Dynatrace and Datadog was just too great to…
Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…
Sale of 100 Dynatrace and purchase of 200 shares of Confluent The market continues in a risk off pattern this Monday morning. Many stocks are still reacting to the perceived read-through from the results of MongoDB. As I tried to suggest, Mongo’s issues are grossly exaggerated, and really are not representative of what is actually…
Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…
Sale of 250 shares of Nutanix; Sale of 100 shares of Dynatrace; purchase of 150 shares of AppLovin; Purchase of 20 shares of CyberArk We made some changes to the high growth portfolio today. In general, my strategy is to hold positions long term. But sometimes, when I see tactical opportunities, I take them. I…
Sale of 500 DT shares and purchase of 1000 shares of NU and 30 shares of Datadog We made some portfolio adjustments this morning. We sold 500 shares of Dynatrace at $47.79. We were not pleased with the company’s earnings report-particularly its forward guidance for ARR growth. After a couple of quarters of mentally making…